Evidence map›Paper›PMID 42872059›Full record

ArticlePatient preference and adherence2026

Association of Physician-Patient Communication and Treatment Satisfaction with Adherence to Disease-Modifying Therapies Among Patients with Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional Study.

Justyna Chojdak-Łukasiewicz, Aleksandra Kołtuniuk, Gianluca Pucciarelli, Sławomir Budrewicz, Anna Pokryszko-Dragan

Abstract read
In one paragraph

Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Justyna Chojdak-ŁukasiewiczClinical Department of Neurology, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0002-0777-4565
Aleksandra KołtuniukDepartment of Nursing, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0002-4377-5987
Gianluca PucciarelliDepartment of Nursing, Wroclaw Medical University, Wroclaw, Poland.
Sławomir BudrewiczClinical Department of Neurology, Wroclaw Medical University, Wroclaw, Poland.
Anna Pokryszko-DraganClinical Department of Neurology, Wroclaw Medical University, Wroclaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adherence to disease modifying therapies (DMTs) is essential for treatment outcomes in relapsing-remitting multiple sclerosis (RRMS). Non-adherence has been associated with an increased risk of relapses, disease progression and higher healthcare costs; therefore, it is essential to identify factors associated with adherence. Purpose: The aim of the study was to evaluate self-reported adherence to therapeutic recommendation among patients with RRMS and to examine its associations with treatment satisfaction and physician-patient communication. Material and Methods: This cross-sectional online survey study included 165 patients with RRMS (67.27% women), with mean age 44.42 ± 10.43 years, treated at the Department of Neurology, Wroclaw Medical University. Adherence was assessed using the Adherence in Chronic Diseases Scale (ACDS), physician-patient communication with the 14-item Polish version of the Communication Assessment Tool (CAT), and treatment satisfaction with the SATMED-Q questionnaire. Associations with the ACDS score were examined by univariable linear regression and by a multivariable model specified a priori on conceptual and clinical grounds (CAT, SATMED-Q, age, sex, EDSS, comorbidities, place of residence, route of administration and disease duration), supported by regression diagnostics and by ordinal and robust-regression sensitivity analyses. Results: The mean ACDS score was 25.49 ± 2.51 (range 14-28). Applying the established cut-offs, 8 participants (4.8%) were classified as showing low, 80 (48.5%) intermediate and 77 (46.7%) high adherence. Patients reported high satisfaction with physician communication (mean CAT score: 61.61 ± 9.73) and with treatment (mean total SATMED-Q score 78.67 ± 15.91). In the a-priori multivariable model (n = 165; Conclusion: In this single-centre cross-sectional sample of patients with RRMS, higher self-reported treatment satisfaction and more favourable ratings of physician-patient communication were associated with modestly higher self-reported adherence scores, while greater disability was associated with lower adherence. Longitudinal and intervention studies are required to establish directionality and to determine whether communication-focused or shared decision-making interventions can improve adherence to disease-modifying therapies.

Indexed as

adherencecross-sectional studiesmultiple sclerosisphysician-patient communicationtreatment satisfaction

Identifiers

PMID42872059
PMCPMC13660504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.